The study took place on a cardiac intensive care unit and 1548 patients. Target levels for glycemia have fluctuated since 2000, as evidence initially indicated t. Critically ill patients can acutely develop extreme insulin resistance, and intravenous insulin infusion is the treatment of choice. The purpose of this study was to compare intensive insulin therapy and conventional therapy in terms of ventilator days, neurosurgical intensive care unit nsicu stay, glasgow outcome scale gos, and complications for patients. Randomized trials of intensive insulin therapy have reported inconsistent effects on mortality and increased rates of severe hypoglycemia. Insulin and the critically ill critical care full text. Making it safe and effective klonoff j diabetes sci technol vol 5, issue 3, may 2011. Control of hyperglycemia in surgical intensive care unit icu patients, those. Intensive insulin therapy and mortality among critically.
We conducted a metaanalysis to update the totality of evidence regarding the influence of intensive insulin therapy compared with conventional insulin therapy. Nondiabetic, critically ill patients frequently develop elevated blood sugar. Strict glycaemic control in patients hospitalised in a. Intensive insulin therapy in critical illness ats journals. We examined the effect of permissive underfeeding compared with that of target feeding and of intensive insulin therapy iit compared with that of conventional insulin therapy cit on the outcomes of critically ill patients. Intensive insulin therapy iit with tight glycemic control may reduce mortality and morbidity in critically ill patients and has been widely adopted.
Target levels for glycemia have fluctuated since 2000, as evidence initially indicated. The glucontrol trial evaluated the role of intensive insulin therapy 4. To evaluate the clinical outcomes of glycemic control of intensive insulin therapy and recommend its place in the. Intensive insulin therapy in critica lly ill patients article pdf available in new england journal of medicine 34519. Hyper and hypoglycemia are associated with increased mortality of critically ill patients, but whether this association is causal remains unclear. Aug 10, 2010 the purpose was to investigate whether intensive insulin therapy iit to keep blood glucose levels from 80 to 110 mgdl or conventional treatment to keep levels less than 151 mgdl was associated with a reduction of mortality and improved functional outcome in critically ill neurologic patients. Nondiabetic, critically ill patients frequently develop elevated blood sugar concentrations 110 mgdl.
Intensive glucose management in critically ill patients. Intensive insulin therapy not recommended for critically ill. You dont feel the effects of low blood sugar hypoglycemia unawareness. Intensive insulin treatment iit targeting blood glucose at 4. Pdf insulin therapy in critically ill patients researchgate. Target levels for glycemia have fluctuated since 2000, as evidence initially indicated that tight glycemic control to socalled normoglycemia. The goal of intensive insulin therapy for critically ill patients is to control blood glucose levels asclose to normal as possible. You struggle with frequent or severe bouts of low blood sugar.
However, there is only one randomized controlled trial showing unequivocal benefit to this approach and that study population was dominated by postcardiac surgery patients. Randomized allocation concealed, blinded patients and outcome asessors, controlled trial with mean followup of 23 days. In order to clarify this matter, we conducted a metaanalysis to assess the use of intensive insulin therapy in managing glycemic control for septic. Intensive versus conventional insulin therapy in critically. Intensive insulin therapy and mortality among critically ill. Intensive insulin therapy after decompression surgery for. Intensive insulin therapy in critical care diabetes care.
Permissive underfeeding and intensive insulin therapy in critically ill patients. Although sepsis is the chief cause of death in icus, whether the impact and safety of intensive insulin therapy in septic patients are the same as those in critically ill patients is uncertain. Increasing evidence supports implementation of intensive insulin therapy iit in critical illness. We conducted a metaanalysis to update the totality of evidence regarding the influence of intensive insulin therapy compared with conventional insulin therapy on. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients. Hyperglycemia is associated with increased mortality in critically ill patients. Hyperglycemia and insulin resistance are common in critically ill patients, even if they have not previously had diabetes. May 01, 2002 in patients who are critically ill, does normalization of blood glucose levels with intensive insulin therapy reduce mortality and morbidity. Permissive underfeeding and intensive insulin therapy in. Intensive insulin therapy in the critically ill geriatric. Tight glucose control can significantly improve outcomes of critically ill geriatric patients in the critical care unit ccu. Intensive insulin therapy in mixed medicalsurgical.
We therefore independently manipulated blood glucose and plasma insulin levels in burninjured, parentally fed rabbits over 7 days to obtain four study groups. Survival benefits of intensive insulin therapy in critical. Intensive insulin therapy in critically ill patients. Using continuous glucose monitoring cgm, we investigated whether intensive insulin therapy based on discontinuous glucose monitoring can achieve normoglycemia 80110 mgdl in a medical intensive. Objectivehyperglycemia occurs in most critically ill patients. Conclusions intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit. In order to clarify this matter, we conducted a metaanalysis to assess the use of intensive insulin therapy. Intensive insulin therapy iit with tight glycemic control may reduce mortality and morbidity in critically ill patients and has been widely adopted in practice throughout the world. Close links between hyperglycemia in hospitalized patients and poor clinical outcomes have been demonstrated in a variety of hospital settings, such as during critical illness, after cardiothoracic surgery, organ transplant, stroke, and trauma, and even in general medical wards. The benefit of intensive insulin therapy was attributable to its effect on mortality among patients who remained in the intensive care unit for more than five days 20. To warrant treatment, hyperglycemia must reach certain thresholds and persist over time. Intensive insulin infusion in critically ill hospitalized patients. Intensive insulin therapy and mortality in critically ill. Intensive insulin treatment reduced the number of deaths from multiple organ failure with sepsis.
Intensive insulin therapy in the medical icu not so sweet. Intensive insulin therapy in critically ill patients nejm. Metabolic effects of intensive insulin therapy in critically. In published trials insulin treatment was required in. Such patients may meet the definition of being critically ill. Intensive insulin therapy targeting tight blood glucose control is of benefit in critically ill patients hyperglycaemia is a common accompaniment of acute illness. Whether the normalization of blood glucose levels with insulin therapy improves the prognosis for such patients. Intensive versus conventional glucose control in critically ill patients. Pdf intensive insulin therapy in critically ill patients. Mar 19, 2020 intensive insulin therapy is recommended for most people who have type 1 diabetes and for some people who have type 2 diabetes but it isnt right for everyone. Pdf permissive underfeeding and intensive insulin therapy.
Moreover, it appears that absolute glucose concentrations that are very high or very low are not the only factors contributing to the harm of dysglycemia in the critically ill. No prospective trials have been conducted stratifying the effects of iit on hyperglycemic patients. Intensive insulin therapy reduced mortality and morbidity in critically ill patients. However, the appropriate caloric intake for critically ill patients remains ill defined.
Dec 01, 2010 insulin therapy in critically ill patients samer ellahhamsamer ellahham and associates, falls church, va, usaabstract. Apr 18, 2002 in a prospective, randomized, controlled study involving adults admitted to surgical intensive care units and receiving mechanical ventilation, intensive insulin therapy substantially reduced mortality and morbidity. Intensive versus conventional glucose control in critically. Intensive insulin therapy for critically ill patients. Such patients may meet the definition of being critically ill and criteria for conditions where there is a high probability of imminent or life threatening. Economic benefits of intensive insulin therapy in critically. Intensive insulin therapy in critical illness american. We found that bringing glycemic level to normal or near normal in critically ill patients does not reduce mortality or the incidence of infection, dr. Intensive insulin therapy iit improves the outcome of prolonged critically ill patients, but concerns remain regarding potential harm and the optimal blood glucose level. Intensive insulin therapy iit for hyperglycemia in critically ill patients has become a standard practice. Critical care visits and neonatal intensive care codes. Close links between hyperglycemia in hospitalized patients and poor clinical outcomes have. Economic benefits of intensive insulin therapy in critically ill patients the targeted insulin therapy to improve hospital outcomes triumph project archana r.
Pdf intensive insulin therapy in critically ill patients researchgate. The diverse effects of insulin may have a profound effect on mortality. Intensive insulin therapy in critically ill hospitalized. Patients randomly assigned to intensive goal 80110 mgdl vs. Intrafacility transport of critically ill patients. Tight blood glucose control with insulin reduces morbidity and mortality of critically ill patients. In 2001, a large rct comparing the effects of a new form of intensive insulin therapy against conventional insulin therapy on surgical intensive care patients was halted early due to the detection.
Target levels for glycemia have fluctuated since 2000, as evidence initially indicated that tight glycemic control to socalled normoglycemia 80110 mgdl leads to the lowest morbidity and mortality without hypoglycemic complications. Traditionally, intensivists did not administer insulin until blood glucose levels exceeded. In the past, blood glucose levels were managed by a pointofcare testing every 4 to 6 hours and using a sliding scale of insulin therapy. Softwareguided intensive insulin therapy in the critically ill rattan diabetes sci technol ol, issue 2, march 20. On the other hand, the risk of harmsnamely hypoglycemiais likely to increase with intensive insulin therapy, he said. A recent study has confirmed the importance of maintaining good glycaemic control in the critically ill patient. Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit. The single center leuven surgical trial in 2001, so named because it took place in the belgian city and involved predominantly surgical patients, randomized 1,548 surgical icu patients to intensive glycemic control goal glucose 80110 mgdl vs. Intensive insulin therapy and mortality among critically ill patients.
However, insulin might have had a role independent of its effect on glycemia. Because intrafacility transport is associated with adverse physiologic changes and adverse. Patient survival 20, duration of intensive care unit icu. Intensive insulin therapy in the intensive care unit. Intensive insulin therapy in critically ill hospitalized patients. The study took place on a cardiac intensive care unit and 1548 patients were enrolled. In the conventional group, insulin infusion started if blood glucose bg 215 mgdl. Early randomizedcontrolled studies compared insulin infusion targeting agenormal blood glucose levels, labeled intensive insulin therapy, with an approach that considered hyperglycemia as a beneficial adaptation. Intensive insulin therapy and mortality in critically ill patients critical. Conclusions intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive. Background the optimal target range for blood glucose in critically ill patients remains unclear.
Please refer to newer 2016 clinical guidelines above guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. Dec 01, 2010 the glucontrol trial evaluated the role of intensive insulin therapy 4. Hyperglycemia is common in critically ill hospitalized patients and it is associated with adverse outcomes, including increased mortality. However, the relative impact of maintaining normoglycemia and of glycemiaindependent actions of insulin remains unknown. To evaluate the clinical outcomes of glycemic control of intensive insulin therapy. Severely ill patients in intensive care units have a cytokine storm with release of tumor necrosis factor. Intensive insulin therapy has been proposed as the treatment of choice for hyperglycemia in critically ill hospitalized patients. Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia. Traditionally, intensivists did not administer insulin until blood glucose levels exceeded 180 to 200 mgml, based on the rationale that mild elevations were not deleterious, and tighter control might be complicated by lifethreatening hypoglycemia. The use of intensive insulin therapy to maintain blood glucose at a level that did not exceed 110 mg per deciliter substantially reduced mortality in the intensive care unit, inhospital mortality, and morbidity among critically ill patients admitted to our intensive care unit. Critical care author information provided at the end of the text. Intensive insulin therapy for critically ill patients kelly s lewis, sandra l kanegill, mary beth bobek, and joseph f dasta. Insulin also induces hypokalaemia, hypohosphtaemia and antinatriuresis.
Intensive insulin therapy also reduced morbidity by preventing organ failure as evidenced by a reduction of duration of mechanical ventilation, by a decrease in the incidence of acute kidney. Correspondence from the new england journal of medicine intensive insulin therapy in critically ill patients. There are no published guidelines for the treatment of transient extreme insulin resistance in critically ill patients, and after the insulin resistance breaks, patients. Research paper is intensive glucose control bad for. Intensive insulin therapy reduced mortality and morbidity in. The new england journal of medicine emory university. Methods within 24 hours after admission to an intensive care unit icu, adults who were expected t. Patient survival 20, duration of intensive care unit icu admission 12, and time to recovery of normal physiological function 59 are inversely correlated with loss of lean body mass.
1537 48 914 1541 303 1570 1104 916 1272 1011 486 259 962 9 420 1324 1204 1044 117 1156 1390 312 431 1521 1317 896 300 212 223 384 752 955 520 887 1431 807 49 692 569 191 598 191